Professor, LSUHSC Section of Infectious Diseases; Love clinical microbiology, antibiotic stewardship, and general infectious diseases; New Orleanian
NOLA, USA
Joined February 2009
- Tweets1.1K
- Following3.2K
- Followers784
- Likes4.6K
Julio Figueroa retweeted
Never a dull moment in ID @IDSAInfo @IDWeekmtg
Oya virus, an orthobunyavirus, was identified in a 54-year-old woman who had sepsis-like symptoms, including leukocytosis, thrombocytopenia, elevated liver-function values, and disseminated intravascular coagulation. Full case details: nej.md/3V6kSuM
ALT Timeline of a clinical course highlighting the treatment and progression of severe Oya virus infection in a patient who also had hepatitis, enteritis, and signs of coagulopathy. It tracks hospital admissions, symptoms, treatments, and recovery progress. Key details include initial symptoms like fever and chills, transfer to Guangzhou Eighth People's Hospital, various treatments such as ibuprofen, antibiotics, antivirals, and plasma transfusion, and the resolution of symptoms. The chart ends with the patient's discharge and follow-up.
Julio Figueroa retweeted
IDWeek is excited to welcome @Atul_Gawande as the speaker for this year’s Opening Plenary, followed by a panel discussion on how collaboration across disciplines is essential to driving the infectious diseases field forward.
Register for #IDWeek2026: idweek.org/registration
Julio Figueroa retweeted
Infective Endocarditis: Diagnosis, Antibiotic Therapy, and Management
ahajrnls.org/4zZy0lp
Julio Figueroa retweeted
37% of congenital syphilis cases occur in mothers who were not screened in a timely manner.
Early diagnosis is key to better outcomes. This @UW_IDEA lesson presents a visual guide to signs of congenital syphilis and guidance for treating and monitoring this condition. amaedhub.org/4xxpKr7
Julio Figueroa retweeted
Updated IDSA Guidelines out now! IDSA has released updated evidence-based guidelines on COVID-19, influenza, and RSV vaccinations in the immunocompromised population.
Access the guidelines: bit.ly/4qNof5u
Our press release: bit.ly/4y9Saau
Julio Figueroa retweeted
On Bob Garry, and the impact of the US administration on his (excellent) research bloomberg.com/news/features/…
Julio Figueroa retweeted
Quantifying quality care: the financial argument for protecting time for quality improvement work by infectious diseases physicians
✅ Just Accepted
🔗 bit.ly/4y5QH52
Julio Figueroa retweeted
The Clean Margin in Diabetic Foot Osteomyelitis: Conceptual Appeal, Practical Uncertainty
🔁 Repost
🔗 bit.ly/3TymMUa
Julio Figueroa retweeted
Who should prioritize a COVID-19 vaccine this fall? People at higher risk for severe illness, people with certain underlying health conditions, people with compromised immune systems and pregnant people, advises IDSA CEO @DrJeanneM.
Watch our briefing: bit.ly/4xkBPju
Julio Figueroa retweeted
Congratulations @Wiki_Guidelines on publication of the latest guideline, on management of complications of persons who inject drugs! Great job team! Let's spread widely! amjmed.com/article/S0002-934…
@ABsteward
Julio Figueroa retweeted
For 75 years, @CDCgov's Epidemic Intelligence Service (EIS) officers have served as “disease detectives,” investigating outbreaks and emerging health threats globally. IDSA celebrates 75 years of EIS and its lasting impact on public health.
Learn more: bit.ly/46puhjl
Julio Figueroa retweeted
🔥Just published 🔥
IDSA/ACEP/ASM/PIDS/SCCM/SHEA/SHM/SIDP Multisociety Position Paper: Hospital Strategies to Improve Sepsis Outcomes #idxposts academic.oup.com/cid/article…
Julio Figueroa retweeted
Meet the newest voices behind #LetsTalkID!
ID physicians @KellyCawcuttMD and @Cortes_Penfield join the podcast as co-hosts for episodes focused on research published in IDSA journals. (1/2)
Julio Figueroa retweeted
This piece took a few years to write but captures something critical to diagnosis—especially in infectious disease. w/ great colleagues Debbie Korenstein & Dan Diekema
jamanetwork.com/journals/jam…
Julio Figueroa retweeted
Antimicrobial resistance is a growing public health threat that demands action. Thank you @SenatorHassan for your leadership and for recognizing the importance of investing in new antibiotics so physicians can continue providing lifesaving care. #PASTEURAct
Julio Figueroa retweeted
Because we cannot relay on @HHSGov any longer, state epidemiologists have created their own disease monitoring system usdiseasetracker.org/ with an initial focus on vaccine-preventable diseases @bylenasun @SherylNYT @apoorva_nyc @ReporterGoodman @corinnepurtill Interesting times indeed
Julio Figueroa retweeted
A strong infectious diseases workforce is essential to protecting patients, stresses IDSA member Vera Luther, MD, FIDSA. #ValueofID
Thank you, Sen. @CortezMasto, for raising this critical issue during yesterday's @SenFinance hearing.
Julio Figueroa retweeted
Tomorrow, IDSA member Vera Luther, MD, MS, FIDSA, will testify before Congress on the growing threat of AMR & the urgent need to strengthen the nation's response.
Read her testimony (bit.ly/4fDobRW) & watch the hearing tomorrow @ 10am ET: bit.ly/4yWWISI